Roh Jong-Lyel, Choi Seung-Ho, Lee Sang-Wook, Cho Kyung-Ja, Nam Soon Yuhl, Kim Sang Yoon
Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
J Surg Oncol. 2008 May 1;97(6):533-7. doi: 10.1002/jso.20993.
Cancers of the submandibular gland are uncommon and only a few small series have reported patient survival and prognosis.
We examined the treatment outcomes of 62 patients with surgically treated submandibular gland carcinomas. All patients underwent surgical excision with/without neck dissection, and 41 received postoperative radiotherapy for high-grade, invasive, positive margin, or regionally metastatic tumors. The locoregional control and survival rates were calculated by the Kaplan-Meier method and prognostic factors were calculated from uni- and multivariate analyses.
Of the 62 submandibular gland carcinomas, 19 were adenoid cystic, 11 were mucoepidermoid, and 10 were salivary duct carcinomas, and 8 were carcinomas in pleomorphic adenoma. Actuarial 5-year locoregional control, distant metastasis-free survival, disease-free and overall survival rates were 69.7%, 65.8%, 52.8%, and 56.8%, respectively. In multivariate analysis, T category and histological grading were prognostic for disease-free survival (P < 0.01), and T category and resection margins were prognostic for locoregional control (P < 0.02). Distant metastases were found in 21 patients (33.9%) at initial staging (n = 2) or follow-up (n = 19).
Despite effective locoregional treatment, approximately one-third of patients with submandibular gland carcinomas may fail systemically, resulting in poor survival. New, more effective therapies may be required for these patients.
下颌下腺癌并不常见,仅有少数小样本系列报道了患者的生存情况和预后。
我们研究了62例接受手术治疗的下颌下腺癌患者的治疗结果。所有患者均接受了手术切除,部分患者同时进行了颈部清扫,41例患者因肿瘤分级高、具有侵袭性、切缘阳性或存在区域转移而接受了术后放疗。采用Kaplan-Meier法计算局部区域控制率和生存率,并通过单因素和多因素分析计算预后因素。
62例下颌下腺癌中,腺样囊性癌19例,黏液表皮样癌11例,涎腺导管癌10例,多形性腺瘤中的癌8例。5年精算局部区域控制率、无远处转移生存率、无病生存率和总生存率分别为69.7%、65.8%、52.8%和56.8%。多因素分析显示,T分期和组织学分级对无病生存率有预后意义(P < 0.01),T分期和手术切缘对局部区域控制有预后意义(P < 0.02)。21例患者(33.9%)在初始分期(n = 2)或随访(n = 19)时出现远处转移。
尽管局部区域治疗有效,但约三分之一的下颌下腺癌患者可能会出现全身转移,导致生存率较低。这些患者可能需要新的、更有效的治疗方法。